Salmonella Combination Vaccines: Moving Beyond Typhoid
Open Forum Infectious Diseases · 02.06.2023 · 10 (Supplement_1) · S58-S66
DOI: 10.1093/ofid/ofad041 ↗Kurz gefasst
Fachartikel in der Zeitschrift Open Forum Infectious Diseases, online erschienen am 02.06.2023. Verfasst von Calman A MacLennan und 4 weiteren Autor:innen. Beteiligte Einrichtung: Enteric and Diarrheal Diseases, Global Health, Bill & Melinda Gates Foundation, Seattle, Washington, USA. Die Arbeit wurde bisher 58-mal zitiert (Crossref) und nennt 77 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council.
Abstract (Originalsprache)
There is now a robust pipeline of licensed and World Health Organization (WHO)–prequalified typhoid conjugate vaccines with a steady progression of national introductions. However, typhoid fever is responsible for less than half the total global burden of Salmonella disease, and even less among children aged <5 years. Invasive nontyphoidal Salmonella disease is the dominant clinical presentation of Salmonella in Africa, and over a quarter of enteric fever in Asia is due to paratyphoid A. In this article, we explore the case for combination Salmonella vaccines, review the current pipeline of these vaccines, and discuss key considerations for their development, including geographies of use, age of administration, and pathways to licensure. While a trivalent typhoid/nontyphoidal Salmonella vaccine is attractive for Africa, and a bivalent enteric fever vaccine for Asia, a quadrivalent vaccine covering the 4 main disease-causing serovars of Salmonella enterica would provide a single vaccine option for global Salmonella coverage.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Enteric and Diarrheal Diseases, Global Health, Bill & Melinda Gates Foundation, Seattle, Washington, USA.
- Jenner Institute, University of Oxford, Oxford, United Kingdom.
- Institute for Health Metrics and Evaluation, University of Washington, Seattle, Washington, USA.
ORCID-Profile: Calman A MacLennan
Förderung
- Medical Research Council
Zitieren
APA
MacLennan, C. A., Stanaway, J., Grow, S., Vannice, K., & Steele, A. D. (2023). Salmonella Combination Vaccines: Moving Beyond Typhoid. Open Forum Infectious Diseases, 10(Supplement_1), S58-S66. https://doi.org/10.1093/ofid/ofad041
Vancouver
MacLennan CA, Stanaway J, Grow S, Vannice K, Steele AD. Salmonella Combination Vaccines: Moving Beyond Typhoid. Open Forum Infectious Diseases. 2023;10(Supplement_1):S58-S66. doi:10.1093/ofid/ofad041
BibTeX
@article{MacLennan2023,
author = {MacLennan, Calman A and Stanaway, Jeffrey and Grow, Stephanie and Vannice, Kirsten and Steele, A Duncan},
title = {Salmonella Combination Vaccines: Moving Beyond Typhoid},
journal = {Open Forum Infectious Diseases},
year = {2023},
volume = {10},
number = {Supplement_1},
pages = {S58--S66},
doi = {10.1093/ofid/ofad041}
}
EUVIMED